Codexis Inc reports results for the quarter ended in December - Earnings Summary

Codexis

29/02/2024 02:01

* Codexis Inc  CDXS.OQ  reported a quarterly adjusted loss
of 10
cents​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of -14
cents.  The mean expectation of seven analysts for the quarter
was for a loss of 12 cents per share. Wall Street expected
results to range from -31 cents to -3 cents per share.
    * Revenue fell 40.4% to $18.10 million from a year ago;
analysts
expected $19.06 million. 
    * Codexis Inc's reported EPS for the quarter was a loss
of 10
cents​.
    * The company reported a quarterly loss of $7.19 million.
    * Codexis Inc shares had risen by 36.1% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Codexis Inc is
$5.00 
This summary was machine generated from LSEG data February 29 at
02:01 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.12          -0.10          Beat
 Sep. 30 2023      -0.32          -0.50          Missed
 Jun. 30 2023      -0.21          -0.17          Beat
 Mar. 31 2023      -0.31          -0.34          Missed